
AI Digest · FDA decision on BPC-157 before 2027 keeps losing ground as the month closes
The chance that the FDA moves BPC-157 into Category 1 before 2027 stands at 9% and leads. It was unchanged over the last day and has slid since its mid-October high. The month's biggest swing came in mid-October, when the chance jumped from 18% to 42% and then faded. BPC-157 is a peptide sold by compounding pharmacies. Category 1 placement would restore their ability to make it.